NEOADJUVANT

Clinical trials for NEOADJUVANT explained in plain language.

Never miss a new study

Get alerted when new NEOADJUVANT trials appear

Sign up with your email to follow new studies for NEOADJUVANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

Triple therapy shows promise against rare sarcoma in early trial

Disease control Ongoing

This study tests whether combining an immunotherapy drug (pembrolizumab) with another immune-boosting protein (eftilagimod alpha) and radiation therapy can shrink soft tissue sarcomas before surgery. About 40 adults with high-risk, non-spread sarcomas will receive this combinatio…

Matched conditions: NEOADJUVANT

Phase: PHASE2 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Disease control

Last updated May 05, 2026 11:56 UTC

NEOADJUVANT

Get alerted when new NEOADJUVANT trials appear

Triple therapy shows promise against rare sarcoma in early trial